Hansei Solutions Celebrates 10 Years of Supporting Access to Behavioral Health Treatment
From regional startup to national leader: Hansei has scaled its behavioral health RCM services to providers across 42 states.FRANKLIN, Tenn.,...
Addiction
ARMR Sciences Achieves Major Milestone Toward Overdose Protection, Produces First-Ever Anti-Fentanyl Immune Response in Humans
Interim phase 1/2 data confirm significant anti-fentanyl antibody production at the lowest dose, with a well-tolerated safety profile across all...
MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy
Randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, and dose-response efficacy of oral Ketamir-2 at a leading U.S. cancer center...
Former DEA Section Chief Steps Forward to Challenge Marijuana Rescheduling Process
"As DEA Prepares for June 29 Hearing, MMJ International Holdings Brings Forward the Very Experts Who Built, Enforced, and Understand...
cliexa and OpiSafe Announce Strategic Partnership to Deliver Comprehensive AI-Powered Opioid Stewardship and Behavioral Health Platform
Integrated Solution Combines Mayo Clinic Platform-Qualified OUD Risk Prediction and Patented Opioid Tapering Behavioral Health Referral TechnologiesDENVER, June 15, 2026...
The Centre for Addiction and Mental Health Optimizes Operations and Patient Care with Oracle Fusion Cloud Applications
Canada's largest mental health teaching hospital unifies clinical and administrative systems with AI-powered applications suite to improve visibility, efficiency, and...
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is...
Tris Pharma to Present on Dual NOP/MOP Receptor Agonist in Pain Management and Substance Use Disorder at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, 2026
Cebranopadol is an investigational, first-in-class dual-NMR agonist in development for acute and chronic pain as well as opioid use disorderFive...
Everything But The House (EBTH) Announces Online Auction of Matthew Perry’s Personal Estate
Portion of Proceeds to Benefit The Matthew Perry FoundationCINCINNATI, June 10, 2026 /PRNewswire/ -- Everything But The House (EBTH) is...
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc...
Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia
FDA grants Orphan Drug Designation (ODD) to Tris Pharma’s TRN-257 for the treatment of idiopathic hypersomnia, based on the plausible...
BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting
Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional...
BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board
BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board Dr. Nestler, world-renowned neuroscientist, Dean...
Marijuana Rescheduling or Regulatory Failure? D.C. Appellate Court Will Rule
"As DEA rescheduling cases merge and federal hemp litigation moves to the D.C. Circuit, MMJ argues that companies following FDA...
How T·TIME Is Forcing Sermorelin Prices Down
Young men's telehealth clinic offers injection-free Sermorelin in an accessible all-inclusive monthly pack AUSTIN, TX / ACCESS Newswire / June...
MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1
Agreement Establishes Global Exclusivity Across MIRA's Core Therapeutic Pipeline and Enhances Strategic Flexibility for Future Licensing and Partnership Opportunities MIAMI,...
Hypha Labs Highlights Parallels Between Emerging Psychedelic Industry and Early Cannabis Market Expansion
State-Level Reform, Growing Public Acceptance, and Expanding Market Capitalizations Signal Potential Long-Term Industry Opportunity LAS VEGAS, NV / ACCESS Newswire...
Porch Light Health Launches Porch Light Health University to Expand Access to Practical Addiction Medicine Training
DENVER, June 03, 2026 (GLOBE NEWSWIRE) -- Porch Light Health today announced the launch of Porch Light Health University (PLHU),...
Pilates Addiction Launches Next 300-Territory Expansion Following Record-Breaking First Year
Fast-growing Pilates franchise enters its second year with new available markets nationwide and internationally, accelerating studio openings and growth while...
Pilates Addiction Launches Next 300-Territory Expansion Following Record-Breaking First Year
Fast-growing Pilates franchise enters its second year with new available markets nationwide and internationally, accelerating studio openings and growth while...